Results 21 to 30 of about 74,305 (343)

Alopecia Areata [PDF]

Therapeutische Umschau, 2002
Die Alopecia areata ist eine häufige Krankheit. Die genaue Ursache ist weiterhin nicht klar, auch wenn Hinweise für eine T-zellvermittelte Autoimmunkrankheit bestehen. Genetische, immunologische und psychologische Faktoren spielen eine Rolle. Klinisch handelt es sich meistens um einzelne Zonen nicht vernarbenden Haarausfalls, welche unter einfachen ...
C.-M. Höring, U. Gieler
openalex   +3 more sources

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata

Frontiers in Immunology, 2022
Alopecia Areata (AA) is a common autoimmune disease characterized by non-scarring hair loss ranging from patches on the scalp to complete hair loss involving the entire body. Disease onset is hypothesized to follow the collapse of immune privilege of the
M. Lensing, A. Jabbari
semanticscholar   +1 more source

Alopecia areata – Current understanding and management

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2022
Alopecia areata (AA) is a chronic, immune‐mediated disease characterized by acute or chronic non‐scarring hair loss, with a heterogeneity in clinical manifestations ranging from patchy hair loss to complete scalp and body hair loss. An overview of the up‐
D. Lintzeri, A. Constantinou, K. Hillmann, K. Ghoreschi, A. Vogt, Ulrike Blume‐ Peytavi   +5 more
semanticscholar   +1 more source

Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study

Vaccines, 2022
Limited data concerning the development of autoimmune skin diseases after COVID-19 vaccination are currently available. Recently, a few reports described the development, worsening or recurrence of alopecia areata after the administration of COVID-19 ...
Francesco Tassone, Simone Cappilli, Flaminia Antonelli, Ruggiero Zingarelli, Andrea Chiricozzi, Ketty Peris   +5 more
doaj   +1 more source

Lifestyle Factors Involved in the Pathogenesis of Alopecia Areata

International Journal of Molecular Sciences, 2022
Alopecia areata is a representative inflammatory skin disease that is associated with various environmental stimuli. While psychological stress is believed to be a major pathogenetic trigger in alopecia areata, infants and newborns also suffer from the ...
Yoko Minokawa, Y. Sawada, Motonobu Nakamura   +2 more
semanticscholar   +1 more source

The associated burden of mental health conditions in alopecia areata: a population‐based study in UK primary care

British Journal of Dermatology, 2022
Alopecia areata (AA) is a common cause of nonscarring hair loss that can have a profound psychological impact.
A. Macbeth, S. Holmes, M. Harries, W. Chiu, C. Tziotzios, S. de Lusignan, A. Messenger, A. Thompson   +7 more
semanticscholar   +1 more source

Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata

Drug Design, Development and Therapy, 2022
Alopecia areata (AA) is an autoimmune condition that causes patchy hair loss, affecting up to 147 million people globally. Currently, there are no treatments approved by US Food and Drug Administration (FDA) specific for AA, and there are few effective ...
H. Ramírez-Marín, A. Tosti
semanticscholar   +1 more source

Alopecia areata incognita [PDF]

Clinics, 2011
Alopecia areata incognita, also known as diffuse alopeciaareata, is a rare form of alopecia areata described pre-dominantly in young women. In cases of alopecia areataincognita, the typical patchy distribution of hair loss inclassical alopecia areata is absent, but abrupt and intensehair loss is characteristic.
Molina, Luciana, Donati, Aline, Valente, Neusa S. Y, Romiti, Ricardo   +3 more
openaire   +9 more sources

Association between alopecia areata and COVID-19: A systematic reviewCapsule Summary

JAAD International, 2022
Background: COVID-19 may play a role in various immune-related dermatologic conditions. The relationship between COVID-19 and alopecia areata remains unclear. Objective: To review the existing literature for clinical studies and reports investigating the
Rachel E. Christensen, BS, Mohammad Jafferany, MD   +1 more
doaj   +1 more source

Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata

Allergy. European Journal of Allergy and Clinical Immunology, 2022
The mechanisms driving alopecia areata (AA) are still unclear, hindering development of targeted therapeutics. Specific Th2 targeting with dupilumab in AA provides a unique opportunity to dissect its pathogenesis and explore the role of Th2 pathway.
Y. Renert-Yuval, A. Pavel, Ester del Duca, P. Facheris, A. D. Pagan, S. Bose, P. Gómez-Arias, M. Angelov, Jennifer Bares, M. Chima, Y. Estrada, S. Garcet, M. Lebwohl, J. Krueger, E. Guttman‐Yassky   +14 more
semanticscholar   +1 more source